{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T13:25:22Z","timestamp":1648992322647},"reference-count":13,"publisher":"Medical Association of Nippon Medical School","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1272\/jnms.79.111","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T06:45:05Z","timestamp":1337841905000},"page":"111-114","source":"Crossref","is-referenced-by-count":2,"title":["Blood Pressure Control in Patients with Chronic Kidney Disease"],"prefix":"10.1272","volume":"79","author":[{"given":"Kouichi","family":"Utsumi","sequence":"first","affiliation":[{"name":"Department of Neurological, Nephrological, and Rheumatological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichiro","family":"Katsura","sequence":"additional","affiliation":[{"name":"Department of Neurological, Nephrological, and Rheumatological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Iino","sequence":"additional","affiliation":[{"name":"Department of Neurological, Nephrological, and Rheumatological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Neurological, Nephrological, and Rheumatological Science, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. National Kidney Foundation: K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.","DOI":"10.1016\/S0272-6386(02)70054-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Eng I Med J 1998; 339: 1448-1456.","DOI":"10.1056\/NEJM199811123392007"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.3919\/jjsa.69.3101"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.","DOI":"10.1056\/NEJMoa041031"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm051"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. K\/DOQI Clinical practice guideline on hypertension and antihypertensive agents in chronic kidney disease. Am J kidney Dis 2004; 43: S1-S290.","DOI":"10.1053\/S0272-6386(04)00369-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch intern Med 2004; 164: 659-663.","DOI":"10.1001\/archinte.164.6.659"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041365"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000026298.00663.58"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11. Urata H, Kinoshita A, Misono KS, et al.: Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990; 265: 22348-22357.","DOI":"10.1016\/S0021-9258(18)45712-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12. Lewis EJ, Hunsicker LG, Clarke WR: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Eng J Med 2001; 345: 851-860.","DOI":"10.1056\/NEJMoa011303"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2007.02097.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14. Yusuf S, Teo KK, Pogue J, et al.: Telmisartan, ramipril, or both in patients at high risk vascular events. N Eng J Med 2008; 358: 1547-1559.","DOI":"10.1056\/NEJMoa0801317"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/79\/2\/79_111\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T05:25:07Z","timestamp":1642310707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/79\/2\/79_111\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.79.111","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}